These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35871777)

  • 1. Integrating Network Pharmacology, Molecular Docking, and Experimental Validation to Investigate the Mechanism of (-)-Guaiol Against Lung Adenocarcinoma.
    Zeng Y; Pan Y; Zhang B; Luo Y; Tian J; Wang Y; Ju X; Wu J; Li Y
    Med Sci Monit; 2022 Jul; 28():e937131. PubMed ID: 35871777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and metabolic mechanisms of bufalin against lung adenocarcinoma: New and comprehensive evidences from network pharmacology, metabolomics and molecular biology experiment.
    Shi S; Zhao S; Tian X; Liu F; Lu X; Zang H; Li F; Xiang L; Li L; Jiang S
    Comput Biol Med; 2023 May; 157():106777. PubMed ID: 36924737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma.
    Zhao XY; Yang YY; Feng JL; Feng CL
    J Vis Exp; 2023 Mar; (193):. PubMed ID: 36939253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation.
    Liu X; Ren Y; Qin S; Yang Z
    BMC Complement Med Ther; 2024 May; 24(1):202. PubMed ID: 38783288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of Key Ingredient of Astragalus membranaceus on Lung Adenocarcinoma via PI3K/AKT Signaling Clarified by Utilizing Network Pharmacology Approach and Experimental Validation.
    Wang YC; Hui JR; Xiao G; Ma QL
    Chin J Integr Med; 2023 Mar; 29(3):244-252. PubMed ID: 36044117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining the mechanism of action of the Qishan formula against lung adenocarcinoma by integration of network pharmacology, molecular docking, and proteomics.
    Geng X; Chi W; Lin X; Niu Z; Jiang Q; Sui Y; Jiang J
    Medicine (Baltimore); 2023 Mar; 102(13):e33384. PubMed ID: 37000102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19.
    Zhang W; Yang Z; Zhou F; Wei Y; Ma X
    Front Endocrinol (Lausanne); 2022; 13():935906. PubMed ID: 36157452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering the pharmacological mechanisms of Scutellaria baicalensis Georgi on oral leukoplakia by combining network pharmacology, molecular docking and experimental evaluations.
    Hou F; Yu Z; Cheng Y; Liu Y; Liang S; Zhang F
    Phytomedicine; 2022 Aug; 103():154195. PubMed ID: 35667260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Aloin Against Gastric Cancer.
    Gao J; Yang S; Xie G; Pan J; Zhu F
    Drug Des Devel Ther; 2022; 16():1947-1961. PubMed ID: 35757520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of tumor related signaling pathways with known compounds to determine potential agents for lung adenocarcinoma.
    Xu S; Liu R; Da Y
    Thorac Cancer; 2018 Aug; 9(8):974-988. PubMed ID: 29870138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Mechanism of Zilongjin in Treating Lung Adenocarcinoma Based on Network Pharmacology Combined with Experimental Verification.
    Zhang K; Chen X
    Crit Rev Immunol; 2024; 44(5):27-40. PubMed ID: 38618726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the potential mechanism of compound gingerol against liver cancer based on network pharmacology and experimental verification.
    Su M; Wang X; Cao G; Sun L; Ho RJY; Han Y; Hong Y; Wu D
    J Pharm Pharmacol; 2022 Jun; 74(6):869-886. PubMed ID: 35429380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of the Effect and Potential Mechanism of Echinacoside Against Endometrial Cancer Based on Network Pharmacology and in vitro Experimental Verification.
    Shu W; Wang Z; Zhao R; Shi R; Zhang J; Zhang W; Wang H
    Drug Des Devel Ther; 2022; 16():1847-1863. PubMed ID: 35734366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics analysis and in vivo validation study of Ophiocordyceps sinensis (Berk.)G.H.Sungetal against lung adenocarcinoma.
    Zhang X; Wang M; Liang X; Wang J; Zhang M; Li C; Wei L; Bi H
    J Ethnopharmacol; 2023 Dec; 317():116739. PubMed ID: 37315647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of astragaloside Ⅳ alleviating PC12 cell injury by activating PI3K/AKT signaling pathway: based on network pharmacology and in vitro experiments].
    Zhang TQ; Li CC; Zhang TF; Wang MY; Cui SN; Huo Q
    Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(24):6465-6473. PubMed ID: 34994139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
    Ni KW; Sun GZ
    Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway.
    Zhu HE; Yin JY; Chen DX; He S; Chen H
    Cell Death Dis; 2019 Nov; 10(11):854. PubMed ID: 31699997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.